Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Glyburide

U.S. FDA Requirements: Glyburide

Pharmaceutical / Drug Definition : Increases insulin binding and sensitivity at receptor sites, stimulating insulin release from beta cells in pancreas and reducing blood glucose level. Also decreases production of basal glucose in liver, enhances sensitivity of peripheral tissue to insulin, inhibits platelet aggregation, and causes mild diuresis

Registrar Corp assists Glyburide companies with:

  • FDA Registration Glyburide
  • FDA Listing Glyburide
  • FDA Label Requirements and Exceptions Glyburide
  • FDA Import Information Glyburide
  • FDA Detentions Glyburide (Glyburide Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Glyburide (Glyburide Suppliers)
       - Processors Glyburide
       - Repackers Glyburide
       - Relabelers Glyburide
       - Exporters Glyburide
       - Importers Glyburide
For more information about Glyburide, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco